CBIH Evaluates a Potential Reg A Offering of Approximately $1,000,000 to Enable Commercial Launch, Statewide Educational Expansion, and Protection of Its Patent Portfolio
CBIH Puts CMS at the Center of the Board: Formal Coordination with Dr. Mehmet Oz's Team and an "Evidence Sprint 2026" Focused on Grants, Research and Clinical Evidence
CBIH Launches Federal and Pharmaceutical Outreach Initiative to Accelerate Medical Cannabis Research in the Schedule III Transition
CBIH Announces New Patent Initiative Targeting Opioid Addiction Through Endocannabinoid Pathways
CBIH Welcomes Federal Momentum Toward Cannabis Rescheduling as 2026 Opens a New Window to Accelerate Medical Innovation and Growth, with CBIH Positioned to Capitalize on Emerging Opportunities
CBIH: Potential Rescheduling to Schedule III Could Reward Decades of Scientific Preparation and Regulatory Discipline
CBIH Announces Women-First Fertility Innovation Built on Nanoemulsion Delivery
Cannabis Bioscience International Holdings, Inc. Appoints Veteran Financier Andy Trivedi to Its Board of Directors, Strengthening Capital Strategy and Growth Outlook
CBIH Ignites Texas: Statewide TCUP Seminar Marks a New Era for Medical Cannabis-With Evidence, Safety, and Patient Dignity at the Center
Brian Cuban to Represent CBIH in DEA Hearings on Marijuana Reclassification
Cannabis Bioscience International Holdings (CBIH) Announces Partnership with Stephen Gould for Manufacturing and Distribution of Medical Products
CBIH Files Petition to Include Alexis Bortell as Witness in DEA Rescheduling Hearing
A Letter from the Desk of CBIH
CBIH Advocates for Cannabis Policy Reform at DEA Reclassification Hearing
CBIH Unveils the Future of Wellness with Revolutionary Anti-Aging Chip
CBIH Strengthens Clinical Research Team in Preparation for Launch of Next-Generation Cannabinoid Solutions
Cannabis Bioscience International Holdings Selected to Participate in DEA Hearing on Cannabis Rescheduling Docket No. 1362 and Hearing Docket No. 24-44
CBIH Welcomes Charles Tamburello to Its Board, Strengthening M&A Strategy
CBIH Strengthens Competitive Advantage with Rapid Expansion of Patent Filings
CBIH Pursues Regulatory Compliance and Market Growth with Essential Licensing Applications
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.